Unique ID issued by UMIN | UMIN000034379 |
---|---|
Receipt number | R000038688 |
Scientific Title | Feasibility study on development of patient question asking support program to prepare for the time of the anti-cancer agent therapy discontinuation |
Date of disclosure of the study information | 2018/10/04 |
Last modified on | 2020/04/06 16:14:07 |
Feasibility study on development of patient question asking support program to prepare for the time of the anti-cancer agent therapy discontinuation
Feasibility study on question asking support program for patients
Feasibility study on development of patient question asking support program to prepare for the time of the anti-cancer agent therapy discontinuation
Feasibility study on question asking support program for patients
Japan |
Colorectal cancer
Gastroenterology |
Malignancy
NO
The Purpose of this study is to develop a patient question asking support program to promote discussion with oncologists on medical treatment/care after discontinuation of anticancer treatment for patients with advanced/recurrent colorectal cancer and to examine the feasibility of the program.
Others
Feasibility
Exploratory
Phase II
Number of questions from patient to doctor
1) The impression of performance during outpatient consultation after question support (control group is about one week later).
2) The number of utterance during outpatient outpatient consultation after question support (control group is open for about one week).
3) Psychological stress of the Patient
4) Patient's QOL
5) Trust in Doctor
6) Satisfuction with consultation
7) Acceptance of cancer in Patients
Interventional
Parallel
Randomized
Cluster
Open -but assessor(s) are blinded
No treatment
2
Educational,Counseling,Training
Maneuver |
Intervention group
Based on the intervention manual, a question asking support program for 40-60min is provided for participants.
Control group
Treatment as usual.
20 | years-old | <= |
Not applicable |
Male and Female
1)Patient is diagnosed as advanced/recurrence colorectal cancer (colon, rectal cancer)
2)Patient receives third line chemotherapy
3)Patient is over 20 years old.
4)Patient's ECOG score is 0 or 1.
5)Patient gives written informedconsent.
6)Patient has ability to read, write and understand Japanese
1) It is judged by the attending physician that there is a decline in severe cognitive function such as delirium, dementia
2) Others are judged unsuitable for conducting this test by the attending physician
20
1st name | Maiko |
Middle name | |
Last name | Fujimori |
National Cancer Center
Center for Public Health SciencesDivision of Health Care Research, QOL Research Group
104-0045
5-1-1 Tsukiji Chuo-ku Tokyo
03-3547-5201(ext.3320)
mfujimor@ncc.go.jp
1st name | Ayako |
Middle name | |
Last name | Sato |
National Cancer Center
Center for Public Health SciencesDivision of Health Care Research, QOL Research Group
104-0045
5-1-1 Tsukiji Chuo-ku Tokyo
03-3547-5201(ext.3327)
ncc2018communication@gmail.com
National Cancer Center
Ministry of Health, Labour and Welfare
Japanese Governmental office
National Cancer Center IRB
5-1-1 Tsukiji Chuo-ku Tokyo
03-3547-5201
NCC_IRBoffice@ml.res.ncc.go.jp
NO
国立がん研究センター中央病院(東京都)
2018 | Year | 10 | Month | 04 | Day |
Unpublished
Completed
2018 | Year | 08 | Month | 24 | Day |
2018 | Year | 08 | Month | 31 | Day |
2018 | Year | 10 | Month | 05 | Day |
2019 | Year | 03 | Month | 31 | Day |
2020 | Year | 01 | Month | 20 | Day |
2020 | Year | 01 | Month | 20 | Day |
2018 | Year | 10 | Month | 04 | Day |
2020 | Year | 04 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038688